Price cuts corner local drugmakers

With multinationals taking up three-quarters of the local drug market, Korean makers will be unable to develop their own drugs if the government’s pressure to reduce medication costs continues, according to market insiders.

Market analysts forecasted that drug makers' revenue will plummet sharply due to reduced medication costs.

They claim that the domestic market will suffer damage of 1...